(in millions $) | 30 Sep 2021 | 30 Jun 2021 | 31 Mar 2021 | 31 Dec 2020 |
---|---|---|---|---|
Current assets | ||||
Cash | $922.48 | $752.58 | $644 | $680.44 |
Short term investments | ||||
Net receivables | $951.17 | $916.37 | $886.22 | $881.02 |
Inventory | ||||
Total current assets | $2075.24 | $1882.11 | $1711.63 | $1748.87 |
Long term investments | ||||
Property, plant & equipment | $481.51 | $496.13 | $525.5 | $535.84 |
Goodwill & intangible assets | $1856.69 | $1883.46 | $1905.34 | $1932.42 |
Total noncurrent assets | $2973.89 | $3016.48 | $3076.29 | $3124.64 |
Total investments | ||||
Total assets | $5049.13 | $4898.59 | $4787.92 | $4873.51 |
Current liabilities | ||||
Accounts payable | $24.83 | $25.19 | $21.57 | $13.91 |
Deferred revenue | ||||
Short long term debt | $441.51 | $441.49 | $90.58 | $340.02 |
Total current liabilities | $1312.35 | $1240.71 | $843.74 | $1202.64 |
Long term debt | $1534.92 | $1562.24 | $1936.63 | $1596.73 |
Total noncurrent liabilities | $1783.9 | $1818.91 | $2194.56 | $1836.65 |
Total debt | $1976.43 | $2003.73 | $2027.21 | $1936.75 |
Total liabilities | $3096.24 | $3059.62 | $3038.3 | $3039.28 |
Shareholders' equity | ||||
Retained earnings | $830.37 | $748.2 | $678.63 | $741.66 |
Other shareholder equity | -$569.61 | -$568.86 | -$561.32 | -$545.34 |
Total shareholder equity | $1952.89 | $1838.97 | $1749.62 | $1834.23 |
(in millions $) | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 | 31 Dec 2017 |
---|---|---|---|---|
Current assets | ||||
Cash | $680.44 | $467.1 | $368.4 | $504.47 |
Short term investments | ||||
Net receivables | $881.02 | $914.25 | $774.18 | $693.09 |
Inventory | ||||
Total current assets | $1748.87 | $1551.68 | $1355.06 | $1433.89 |
Long term investments | $0.84 | $0.89 | ||
Property, plant & equipment | $535.84 | $584.89 | $212.72 | $207.03 |
Goodwill & intangible assets | $1932.42 | $1805.33 | $1570.92 | $1468.71 |
Total noncurrent assets | $3124.64 | $2902.51 | $2174.39 | $2015.73 |
Total investments | $0.84 | $0.89 | ||
Total assets | $4873.51 | $4454.18 | $3529.45 | $3449.62 |
Current liabilities | ||||
Accounts payable | $13.91 | $21.98 | $42.58 | $15.05 |
Deferred revenue | ||||
Short long term debt | $340.02 | $161.17 | $328.48 | $209.23 |
Total current liabilities | $1202.64 | $910.21 | $976.31 | $838.78 |
Long term debt | $1596.73 | $1641.9 | $975.64 | $1006.69 |
Total noncurrent liabilities | $1836.65 | $1854.8 | $1148.95 | $1182.04 |
Total debt | $1936.75 | $1803.07 | $1304.13 | $1215.91 |
Total liabilities | $3039.28 | $2765.01 | $2125.26 | $2020.83 |
Shareholders' equity | ||||
Retained earnings | $741.66 | $648.66 | $438.45 | $355.98 |
Other shareholder equity | -$545.34 | -$531.96 | -$507.46 | -$355.23 |
Total shareholder equity | $1834.23 | $1689.17 | $1404.18 | $1424.04 |
(in millions $) | 30 Sep 2021 | 30 Jun 2021 | 31 Mar 2021 | 31 Dec 2020 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $1015.74 | $988.13 | $946.07 | $950.57 |
Cost of revenue | $653.69 | $632.98 | $600.93 | $613.64 |
Gross Profit | $362.05 | $355.14 | $345.14 | $336.92 |
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | $215.96 | $204.17 | $200.73 | $207.86 |
Total operating expenses | $229.76 | $218.24 | $217.26 | $223.87 |
Operating income | $132.29 | $136.9 | $127.88 | $113.05 |
Income from continuing operations | ||||
EBIT | $136.5 | $148.5 | $132.57 | $111.22 |
Income tax expense | $21.35 | $32.7 | $28.95 | $25.35 |
Interest expense | $12.77 | $13.09 | $12.34 | $10.89 |
Net income | ||||
Net income | $102.39 | $102.7 | $91.27 | $74.98 |
Income (for common shares) | $102.39 | $102.7 | $91.27 | $74.98 |
(in millions $) | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 | 31 Dec 2017 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $3709.38 | $3520.54 | $3000.79 | $2736.93 |
Cost of revenue | $2418.14 | $2294.69 | $1921.77 | $1683.7 |
Gross Profit | $1291.24 | $1225.86 | $1079.02 | $1053.22 |
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | $789.85 | $794.9 | $693.87 | $689.85 |
Total operating expenses | $852.52 | $796.48 | $730.87 | $724.6 |
Operating income | $438.72 | $429.38 | $348.15 | $328.63 |
Income from continuing operations | ||||
EBIT | $449.44 | $442.88 | $399.9 | $354.59 |
Income tax expense | $92.2 | $94.54 | $80.76 | $59.74 |
Interest expense | $48.96 | $43.46 | $37.12 | $31.73 |
Net income | ||||
Net income | $308.28 | $304.88 | $282.02 | $263.11 |
Income (for common shares) | $308.28 | $304.88 | $282.02 | $263.11 |
(in millions $) | 30 Sep 2021 | 30 Jun 2021 | 31 Mar 2021 | 31 Dec 2020 |
---|---|---|---|---|
Net income | $102.39 | $102.7 | $91.27 | $74.98 |
Operating activities | ||||
Depreciation | $40.42 | $41.42 | $45.13 | $39.9 |
Business acquisitions & disposals | -$1.3 | -$5.31 | -$186.63 | |
Stock-based compensation | $21.48 | $19.69 | $17.43 | $18.19 |
Total cash flows from operations | $209.71 | $160.61 | $77.16 | $159.09 |
Investing activities | ||||
Capital expenditures | -$8.39 | -$9.16 | -$13.23 | -$23.89 |
Investments | $0.14 | |||
Total cash flows from investing | -$8.25 | -$10.47 | -$18.54 | -$210.52 |
Financing activities | ||||
Dividends paid | -$20.21 | -$20.13 | -$20.11 | -$18.44 |
Sale and purchase of stock | $15.03 | -$4.84 | -$127.62 | -$57.65 |
Net borrowings | -$12.38 | -$11.36 | $86.57 | -$6.83 |
Total cash flows from financing | -$20.64 | -$40.58 | -$89.89 | -$90.39 |
Effect of exchange rate | -$10.93 | -$0.99 | -$5.17 | $18.86 |
Change in cash and equivalents | $180.82 | $109.56 | -$31.27 | -$141.82 |
(in millions $) | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 | 31 Dec 2017 |
---|---|---|---|---|
Net income | $308.28 | $304.88 | $282.02 | $263.11 |
Operating activities | ||||
Depreciation | $159.84 | $128.71 | $103.72 | $94.92 |
Business acquisitions & disposals | -$186.63 | -$250.11 | -$116.3 | -$290.06 |
Stock-based compensation | $74.01 | $83.89 | $49 | $35.69 |
Total cash flows from operations | $584.31 | $427.89 | $339.51 | $359.08 |
Investing activities | ||||
Capital expenditures | -$79.76 | -$107.01 | -$159.75 | -$71.93 |
Investments | ||||
Total cash flows from investing | -$266.4 | -$357.12 | -$276.05 | -$361.99 |
Financing activities | ||||
Dividends paid | -$74.21 | -$64.67 | -$57.1 | -$46.69 |
Sale and purchase of stock | -$111.98 | -$10.33 | -$140.02 | -$204.26 |
Net borrowings | $134.81 | $131.3 | $81.31 | $314.66 |
Total cash flows from financing | -$92.01 | $39.65 | -$135.19 | $47.19 |
Effect of exchange rate | -$12.56 | -$11.72 | -$64.35 | $37.57 |
Change in cash and equivalents | $225.9 | $110.42 | -$71.73 | $44.28 |
Outlook on the Health Insurance Global Market to 2027 - Increased Demand for Quality Private Care...
WFMZ Eastern Pennsylvania and Western New Jersey
22 Apr 2022
|
Russia's Invasion of Ukraine to Spur More Claims Inflation: Moody's
Insurance Journal
10 Mar 2022
|
5 Italian Stocks To Consider For Columbus Day
Benzinga via Yahoo Finance
5 Oct 2021
|
Assicurazioni Generali S.p.A. (BIT:G) Goes Ex-Dividend In 3 Days
Simply Wall St. via Yahoo Finance
5 Feb 2020
|
Market cap | N/A |
---|---|
Enterprise value | N/A |
Shares outstanding | N/A |
Revenue | $3.90B |
---|---|
EBITDA | $695.65M |
EBIT | $528.78M |
Net Income | $371.35M |
Revenue Q/Q | 8.57% |
Revenue Y/Y | 5.43% |
P/E ratio | N/A |
---|---|
EV/Sales | N/A |
EV/EBITDA | N/A |
EV/EBIT | N/A |
P/S ratio | N/A |
P/B ratio | N/A |
Book/Share | N/A |
Cash/Share | N/A |
EPS | N/A |
---|---|
ROA | 7.57% |
ROE | 20.14% |
Debt/Equity | 1.66 |
---|---|
Net debt/EBITDA | 3.12 |
Current ratio | 1.58 |
Quick ratio | 1.58 |